509 related articles for article (PubMed ID: 31274341)
1. The Defensive Action of LYRM03 on LPS-Induced Acute Lung Injury by NF-κB/TLR4/NLRP3 Signals.
Wang B; Wang J; Lu D; Qi N; Liu Q
J Invest Surg; 2021 Mar; 34(3):284-296. PubMed ID: 31274341
[TBL] [Abstract][Full Text] [Related]
2. Posttreatment With LYRM03 Protects Rats From Acute Lung Inflammation Induced by Lipopolysaccharide via Suppressing the NF-κB/MyD88/TLR4 Axis.
Jiang Q; Wang S; Shi Y
J Surg Res; 2019 Nov; 243():316-324. PubMed ID: 31255931
[TBL] [Abstract][Full Text] [Related]
3. Yemazhui () ameliorates lipopolysaccharide-induced acute lung injury modulation of the toll-like receptor 4/nuclear factor kappa-B/nod-like receptor family pyrin domain-containing 3 protein signaling pathway and intestinal flora in rats.
Li R; Yang H; Xue Y; Xianqin L
J Tradit Chin Med; 2024 Apr; 44(2):303-314. PubMed ID: 38504536
[TBL] [Abstract][Full Text] [Related]
4. MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line.
Luo M; Hu L; Li D; Wang Y; He Y; Zhu L; Ren W
Mol Immunol; 2017 Oct; 90():1-10. PubMed ID: 28654770
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
6. LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway.
He HQ; Wu YX; Nie YJ; Wang J; Ge M; Qian F
Acta Pharmacol Sin; 2017 Mar; 38(3):342-350. PubMed ID: 28112185
[TBL] [Abstract][Full Text] [Related]
7. Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS
Zhang C; Wang X; Wang C; He C; Ma Q; Li J; Wang W; Xu YT; Wang T
Front Pharmacol; 2021; 12():790072. PubMed ID: 35002723
[No Abstract] [Full Text] [Related]
8. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
9. Fortunellin ameliorates LPS-induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF-κB/NLRP3 pathway.
Liu D; Guo R; Shi B; Chen M; Weng S; Weng J
Immun Inflamm Dis; 2024 Mar; 12(3):e1164. PubMed ID: 38501503
[TBL] [Abstract][Full Text] [Related]
10. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
[TBL] [Abstract][Full Text] [Related]
11. Bakuchiol regulates TLR4/MyD88/NF-κB and Keap1/Nrf2/HO-1 pathways to protect against LPS-induced acute lung injury in vitro and in vivo.
Zhao L; Zhang Z; Li P; Gao Y; Shi Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3301-3312. PubMed ID: 37930390
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
14. Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats.
Wu Y; Huang D; Wang X; Pei C; Xiao W; Wang F; Wang Z
Int Immunopharmacol; 2021 Jul; 96():107621. PubMed ID: 33872850
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect and component analysis of Chaihu Qingwen granules.
Zhou Y; Li QX; Liao ZZ; Liu Y; Ouyang Y; Jiang WJ; Tang MT; Hu JF; Zhang W
J Ethnopharmacol; 2023 Dec; 317():116763. PubMed ID: 37315646
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydropalmatine induces the polarization of M1 macrophages to M2 to relieve limb ischemia-reperfusion-induced lung injury via inhibiting the TLR4/NF-κB/NLRP3 signaling pathway.
Wen H; Lu D; Chen H; Zhu Y; Xie Q; Zhang Z; Wu Z
Drug Dev Res; 2022 Sep; 83(6):1362-1372. PubMed ID: 35976115
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of lung and intestine combination therapy in treatment of acute lung injury by inhibiting inflammatory response based on NF-κB/NLRP3 signaling pathway and alveolar macrophage activation].
Kou YL; Wang WB; Yan SG; Li JT; Shi J; Hui Y
Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):151-158. PubMed ID: 35178922
[TBL] [Abstract][Full Text] [Related]
18. Qinhuo Shanggan oral solution resolves acute lung injury by down-regulating TLR4/NF-
Tang S; Liang Y; Wang M; Lei J; Peng Y; Tao Q; Ming T; Yang W; Zhang C; Guo J; Xu H
Front Immunol; 2023; 14():1285550. PubMed ID: 37954597
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
[TBL] [Abstract][Full Text] [Related]
20. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]